101 related articles for article (PubMed ID: 15542738)
21. [Genetic polymorphisms and human sensitivity to pain and opioids].
Nishizawa D; Nagashima M; Satoh Y; Tagami M; Ikeda K
Masui; 2009 Sep; 58(9):1093-101. PubMed ID: 19764431
[TBL] [Abstract][Full Text] [Related]
22. Gene expression is altered in the lateral hypothalamus upon activation of the mu opioid receptor.
Befort K; Filliol D; Darcq E; Ghate A; Matifas A; Lardenois A; Muller J; Thibault C; Dembele D; Poch O; Kieffer BL
Ann N Y Acad Sci; 2008; 1129():175-84. PubMed ID: 18591478
[TBL] [Abstract][Full Text] [Related]
23. Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain.
Endres-Becker J; Heppenstall PA; Mousa SA; Labuz D; Oksche A; Schäfer M; Stein C; Zöllner C
Mol Pharmacol; 2007 Jan; 71(1):12-8. PubMed ID: 17005903
[TBL] [Abstract][Full Text] [Related]
24. Genomic variations and transcriptional regulation of the human mu-opioid receptor gene.
Bayerer B; Stamer U; Hoeft A; Stüber F
Eur J Pain; 2007 May; 11(4):421-7. PubMed ID: 16843022
[TBL] [Abstract][Full Text] [Related]
25. dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice.
Wu HE; Sun HS; Terashivili M; Schwasinger E; Sora I; Hall FS; Uhl GR; Tseng LF
Eur J Pharmacol; 2006 Feb; 531(1-3):103-7. PubMed ID: 16445907
[TBL] [Abstract][Full Text] [Related]
26. [Side effects of opioid and gene variants].
Sora I; Komatsu H; Igari M; Ide S; Ikeda K; Shimoyama N
Masui; 2009 Sep; 58(9):1109-11. PubMed ID: 19764433
[TBL] [Abstract][Full Text] [Related]
27. The mu-opioid receptor subtype is required for the anorectic effect of an opioid receptor antagonist.
Zhang J; Frassetto A; Huang RR; Lao JZ; Pasternak A; Wang SP; Metzger JM; Strack AM; Fong TM; Chen RZ
Eur J Pharmacol; 2006 Sep; 545(2-3):147-52. PubMed ID: 16876155
[TBL] [Abstract][Full Text] [Related]
28. Identification of three mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon.
Doyle GA; Rebecca Sheng X; Lin SS; Press DM; Grice DE; Buono RJ; Ferraro TN; Berrettini WH
Gene; 2007 Feb; 388(1-2):135-47. PubMed ID: 17156941
[TBL] [Abstract][Full Text] [Related]
29. Acute and chronic fentanyl administration causes hyperalgesia independently of opioid receptor activity in mice.
Waxman AR; Arout C; Caldwell M; Dahan A; Kest B
Neurosci Lett; 2009 Oct; 462(1):68-72. PubMed ID: 19559072
[TBL] [Abstract][Full Text] [Related]
30. The potential promoter regions on the 5' flank sequence of the mu opioid receptor gene in lymphocytes.
Wei E; Li P; Liu X; Qian C; Li H; Xia W; Li G
J Cell Biochem; 2005 Aug; 95(6):1204-13. PubMed ID: 15988758
[TBL] [Abstract][Full Text] [Related]
31. A lack of mu-opioid receptors modulates the expressions of neuropeptide Y and substance P mRNA.
Yoo JH; Cho JH; Lee SY; Loh HH; Ho IK; Jang CG
Neurosci Lett; 2005 Aug 12-19; 384(1-2):29-32. PubMed ID: 15885902
[TBL] [Abstract][Full Text] [Related]
32. Glucocorticoid hormone regulates the circadian coordination of micro-opioid receptor expression in mouse brainstem.
Yoshida M; Koyanagi S; Matsuo A; Fujioka T; To H; Higuchi S; Ohdo S
J Pharmacol Exp Ther; 2005 Dec; 315(3):1119-24. PubMed ID: 16109741
[TBL] [Abstract][Full Text] [Related]
33. Opioid pharmacology.
Trescot AM; Datta S; Lee M; Hansen H
Pain Physician; 2008 Mar; 11(2 Suppl):S133-53. PubMed ID: 18443637
[TBL] [Abstract][Full Text] [Related]
34. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
[TBL] [Abstract][Full Text] [Related]
35. Cannabinoid receptor type 2 agonists induce transcription of the mu-opioid receptor gene in Jurkat T cells.
Börner C; Höllt V; Kraus J
Mol Pharmacol; 2006 Apr; 69(4):1486-91. PubMed ID: 16434616
[TBL] [Abstract][Full Text] [Related]
36. Deletion of mu-opioid receptor in mice alters the development of acute neuroinflammation.
Benamar K; Yondorf M; Barreto VT; Geller EB; Adler MW
J Pharmacol Exp Ther; 2007 Dec; 323(3):990-4. PubMed ID: 17898318
[TBL] [Abstract][Full Text] [Related]
37. [Genetic variation-- important for the clinical effect of opioids?].
Klepstad P; Dale O; Borchgrevink PC; Kaasa S; Skorpen F
Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2655-8. PubMed ID: 16215614
[TBL] [Abstract][Full Text] [Related]
38. Human expression variation in the mu-opioid receptor is paralleled in rhesus macaque.
Vallender EJ; Priddy CM; Chen GL; Miller GM
Behav Genet; 2008 Jul; 38(4):390-5. PubMed ID: 18379868
[TBL] [Abstract][Full Text] [Related]
39. Elevated mu-opioid receptor expression in the nucleus of the solitary tract accompanies attenuated withdrawal signs after chronic low dose naltrexone in opiate-dependent rats.
Van Bockstaele EJ; Rudoy C; Mannelli P; Oropeza V; Qian Y
J Neurosci Res; 2006 Feb; 83(3):508-14. PubMed ID: 16385558
[TBL] [Abstract][Full Text] [Related]
40. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
